Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2004
08/19/2004WO2004021863A3 Methods for measuring rates of replication and death of nfectious microbial agents in an infected host organism
08/19/2004WO2004020663A3 Genetic markers for diagnosing predisposition to heredity or expression of the imperforate anus phenotype in domestic animals, breeding animals and working animals
08/19/2004WO2004016805A9 Immunostimulatory nucleic acids
08/19/2004WO2004007675A3 Neuronal and optic nerve gene expression patterns
08/19/2004WO2004005480A3 Plastid genetic engineering via somatic embryogenesis
08/19/2004WO2004003509A3 A method to identify specific interaction between ligand and receptor
08/19/2004WO2004003136A3 Methods of detecting sequence differences
08/19/2004WO2004001371A3 Receptor capture assay
08/19/2004WO2004000998A3 Compositions and methods for viral resistance genes
08/19/2004WO2003091410A3 Method of fingerprinting tissue samples
08/19/2004WO2003088814A3 Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents
08/19/2004WO2003083047A3 MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
08/19/2004WO2003081206A3 Stratification of patient populations having or suspected of having rheumatoid arthritis
08/19/2004WO2003078450A3 Negatively charged minor groove binders
08/19/2004WO2003074658A3 Multivariate random search method with multiple starts and early stop for identification of differentially expressed genes based on microarray data
08/19/2004WO2003068919A3 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
08/19/2004WO2003066880A3 Method for accessing microbial diversity
08/19/2004WO2003060084A3 Methods for making polynucleotides and purifying double-stranded polynucleotides
08/19/2004WO2003053364A3 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
08/19/2004WO2003040694A3 Enzymatic cycling assays for homocysteine and cystathionine
08/19/2004WO2003039443A3 Novel genetic markers for leukemias
08/19/2004WO2003038123A3 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
08/19/2004WO2003020120A3 Diagnosis and treatment of vascular disease
08/19/2004WO2003006625A8 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
08/19/2004US20040163146 Vascular-preferred promoters
08/19/2004US20040163140 Biological material
08/19/2004US20040163137 PG-3 and biallelic markers thereof
08/19/2004US20040162679 Method for predicting gene potential and cell commitment
08/19/2004US20040162678 Method of screening for disorders of glucose metabolism
08/19/2004US20040162294 Therapeutic use of selective PDE10 inhibitors
08/19/2004US20040162293 Administering to mammal an amount of a selective PDE10 inhibitor effective in treating anxiety or psychotic disorder
08/19/2004US20040162262 Immunomodulatory oligonucleotides
08/19/2004US20040162258 Immunomodulatory oligonucleotides
08/19/2004US20040162254 Antiviral oligonucleotides targeting HSV and CMV
08/19/2004US20040162253 Administering pharmacologically acceptable oligonucleotide at least 10 nucleotides in length, wherein the anti-HBV activity of oligonucleotide occurs principally by a non-sequence complementary mode of action
08/19/2004US20040162252 Administering formulation capable of inhibiting at least one host cell protein needed for replication of a virus
08/19/2004US20040162236 Providing a sample; introducing the sample to an antibody that binds immunospecifically to the polypeptide (containing amino acids from 1 to 82 ); and determining the presence or amount of antibody bound to said polypeptide, thus determining the presence or amount of polypeptide in the sample
08/19/2004US20040161862 Detecting and visualizing latent hybridization pattern of nucleic acids on solid support using labeled proteins and precipitation of colloidal particles; nucleic acid hybridization analysis
08/19/2004US20040161860 Assay with co-immobilized ligands
08/19/2004US20040161840 Bax-Responsive genes for drug target identification in yeast and fungi
08/19/2004US20040161827 Comprises nucleotide sequences coding tumor suppression phosphoprotein for use as pesticide and in treatment of cell proliferative disorders; antitumor agents; bioreactors and in vitro/in vivo drug screening
08/19/2004US20040161825 Sperm specific proteins
08/19/2004US20040161824 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering
08/19/2004US20040161823 for treating, diagnosing, preventing, and drug screening; genetic engineering
08/19/2004US20040161818 for use in pesticide bioremediation strategies; biosensors; genetic engineering; solid phase synthesis
08/19/2004US20040161816 Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
08/19/2004US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering
08/19/2004US20040161813 Structure of beta-ketoacyl-[acyl carrier protein] synthases complexed with inhibitors and methods of use thereof
08/19/2004US20040161812 providing a panel of different quantitative blood tests each capable of providing one of an abnormal result for determining whether a patient whose initial clinical evaluation indicates chronic fatigue syndrome, fibromyalgia
08/19/2004US20040161811 Reagent kit for detecting cholesterol in a high-density lipoprotein
08/19/2004US20040161808 Ligand-specific opening of a gated-porin channel in the outer membrane of living bacteria
08/19/2004US20040161807 using labeled substrate molecules that can be acted upon only by specific oncogenic enzymes; for drug screening
08/19/2004US20040161805 Cardiovascular safety assay
08/19/2004US20040161803 Methods and reagents for identifying weight loss promoters and therpeutic uses therefor
08/19/2004US20040161801 Hybridization detection method and biochips
08/19/2004US20040161797 for drug screening by assessing the effect on localization of signal transduction proteins, particularly the protein kinase C (PKC) isoenzymes
08/19/2004US20040161795 Systems and methods for analysis of protein post-translational modification
08/19/2004US20040161794 Identifying modulators of hypothalamic inhibitory factor for use in treatment, prevention and monitoring hypertension
08/19/2004US20040161793 Identifying chemical modulators which prevent bacterial propagation during infection via inhibition of cell cycle protein (FTSZ) assembly; bactericides
08/19/2004US20040161792 Nucleic acid amplification
08/19/2004US20040161791 Identifying genic position of exons within genome using positionally-addressable ordered microarrays; computer diagnostics and genetic engineering
08/19/2004US20040161790 Thermodynamic prediction model for biochip DNA hybridization information to be inputted into a neural network system
08/19/2004US20040161787 Protein fragment complementation assays for high-throughput and high-content screening
08/19/2004US20040161786 Gene panel participative in hepatic stellate cell activation
08/19/2004US20040161784 Assays for the detection of microtubule depolymerization inhibitors
08/19/2004US20040161783 Using 16s ribosomal RNA subregions for use as differentiative tools in taxonomic classification of mycobacterium
08/19/2004US20040161782 Means and methods for identifying genes and proteins involved in the prevention and/or repair of a replication error
08/19/2004US20040161781 Identifying enzyme inhibitors and modulators which bind specific transcriptional elements for use in treatment of cell proliferative disorders
08/19/2004US20040161780 Using luminescent dyes and colorimetric analysis to detect protein concentration differences in body fluid samples
08/19/2004US20040161779 Methods, compositions and computer software products for interrogating sequence variations in functional genomic regions
08/19/2004US20040161778 Nucleic acid enzyme biosensors for ions
08/19/2004US20040161777 Nucleotide sequences comprising terminal caps and inverted 3'-3' linkage for use in gene expression inhibition and preventing disease
08/19/2004US20040161773 Subtelomeric DNA probes and method of producing the same
08/19/2004US20040161771 Using fluorescence activated cell sorting to identify and separate cell expressing nucleotide sequence coding transcribing interleukin-4
08/19/2004US20040161770 Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
08/19/2004US20040161768 Comprises nucleotide sequences comprising polymorphic variation in multidrug resistant genes for use in diagnosis and treatment of cancer and cardiovascular disorders
08/19/2004US20040161767 Detection and quantification of aromatic oxygenase genes by real-time PCR
08/19/2004US20040161765 Screening for monogenic and polygenic genetic disorders using RNA interference and subtractive hybridization; prevention of premature translation termination
08/19/2004US20040161764 Preparation of calibrants and use thereof in the quantification of nucleotide sequences of interest
08/19/2004US20040161763 Analyzing cytosine methylation in genomic DNA samples using fluorophore incorporation and phosphodiesterases resistance
08/19/2004US20040161762 Novel human poly(a)polymerase gamma (pap gamma)
08/19/2004US20040161761 Genetic testing
08/19/2004US20040161760 Using concentration of expression products from cell proliferation marker to diagnosis and prognose leukemic disorders; gene expression analysis and cancer disorders
08/19/2004US20040161759 Using polymorphism detection to diagnose and prognose psoriasis; gene therapy
08/19/2004US20040161757 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect
08/19/2004US20040161756 Preparing solid support comprising immobilize nucleotide sequences coding receptor and/or enzymatic polypeptides for use in identifying modulators of genic expression
08/19/2004US20040161755 Comprises nucleotide sequences coding kinesin protein for use in diagnosis, treatment or prevention of cancer, nervous system and vesicular transport disorders
08/19/2004US20040161753 Identifying genic sequences of regulatory DNA binding proteins via directed mutational analysis; generating mimetic protein for regulating transcription
08/19/2004US20040161750 Quantitation analysis; attaching one or more target biomolecules to a substrate; using primer to produce one or more rolling circle amplification (RCA) products; detecting each amplification product by Raman spectroscopy; identifying one or more target biomolecules by presence of amplification product
08/19/2004US20040161749 3' end tagged oligonucleotides
08/19/2004US20040161747 Method for screening for autoimmune disease by identifying polymorphisms in il-12 p40
08/19/2004US20040161746 Method of testing allergic disease
08/19/2004US20040161743 Applications with and methods for producing selected interstrand cross-links in nucleic acids
08/19/2004US20040161742 improves upon strand displacement replication; target nucleic acid sequence or whole genome need not be denatured; hexamer primers can be modified to be nuclease resistant; DNA polymerase is bacteriophage phi-29
08/19/2004US20040161741 Microarray comprising immobilized nucleotide sequences and/or derivatives for quantifying RNA expression products
08/19/2004US20040161740 Method of determining the genetic material of cocoa in fermented or roasted beans and chocolate
08/19/2004US20040161739 HIV diagnostic methods
08/19/2004US20040161737 Novel luminescent metal chelates and methods for their detection
08/19/2004US20040161472 Methods of judging mouth odor
08/19/2004US20040161470 Encapsulation of active material in polyphosphazenes